| Mrs Colleen Nichole Lard, MS CCC-SLP | |
|
4401 Penn Ave, Floor 3, Pittsburgh, PA 15224-1334 | |
| (412) 692-5580 | |
| Not Available |
| Full Name | Mrs Colleen Nichole Lard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4401 Penn Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033657093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL011955 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Colleen Nichole Lard, MS CCC-SLP 4401 Penn Ave, Floor 3, Pittsburgh, PA 15224-1334 Ph: (412) 692-5580 | Mrs Colleen Nichole Lard, MS CCC-SLP 4401 Penn Ave, Floor 3, Pittsburgh, PA 15224-1334 Ph: (412) 692-5580 |
News Archive
Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognize cancer cells and target them for destruction.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.
With the latest research estimating that nearly six million people worldwide will lose their lives to tobacco next year, an innovative approach is critical to helping the 43 million Americans who smoke to finally quit. This month, which is observed as Lung Cancer Awareness Month, the national quit smoking program, EX(R) will debut the second phase of advertising and promotions designed to help smokers "re-learn" life without cigarettes.
› Verified 1 days ago
Jessica Wormald, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2695 Winchester Dr, Pittsburgh, PA 15220 Phone: 412-440-4364 Fax: 412-440-4379 | |
Michael Sean O'leary, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1401 Forbes Ave, Sutie 303, Pittsburgh, PA 15219 Phone: 412-402-0900 | |
Stephanie Clouser, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 158 S 17th St, Pittsburgh, PA 15203 Phone: 717-654-3100 | |
Ariana Desai, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 203 Lothrop St, Pittsburgh, PA 15213 Phone: 412-647-6461 | |
Jenna Lynn Burdette, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2603 Shady Ave, Pittsburgh, PA 15217 Phone: 610-751-1967 | |
Katherine Mcgovern, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9100 Babcock Blvd, Pittsburgh, PA 15237 Phone: 412-748-4149 | |
Kimberly Anne Santoro, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 240 Delano Dr, Pittsburgh, PA 15236 Phone: 412-655-4825 |